Bioventus Inc expected to post earnings of 5  cents a share - Earnings Preview

Bioventus

17/03/2023 13:16

* Bioventus Inc  BVS.OQ   BVS.O  is expected to show a rise
in
quarterly revenue when it reports  results on March 30. 
    * The Durham North Carolina-based  company is expected to
report 
a 1.8% increase in revenue to $132.699 million from $130.41
million a year ago, according to the mean estimate from 3
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Bioventus Inc is
for
earnings of 5 cents per share. 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 2
"hold" and 1 "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Bioventus
Inc is
$6.5​, above​ its last closing price of $1.42. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2022  0.12        0.12       0.08      Missed  -34.4
 Jun. 30 2022  0.15        0.16       0.10      Missed  -35.9
 Mar. 31 2022  0.05        0.05       0.04      Missed  -16.7​
 Dec. 31 2021  0.17        0.18       0.26      Beat    46.5
 ​​Sep.        0.14        0.14       0.25      Beat    78.6
 30 2021                                                
 Jun. 30 2021  0.10        0.14       0.16      Beat    16.4​
 Mar. 31 2021  0.10        0.10       0.15      Beat    57.9
 Dec. 31 2020  0.23        0.23       2.32      Beat    908.7
 This summary was machine generated March 17 at 13:16 GMT.  All
figures in US dollars  unless otherwise stated